Last updated: 2026-09-21 21:08:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Abbott Laboratories (ABT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $102.98, with a market capitalization of $177.55B and a P/E ratio of 32.73. Over the past 52 weeks, its price has ranged from $81.97 to $137.49. This page covers its latest market performance, valuation, price trends and company information.
$177.55B | |
$102.27 | |
$142.60 | |
$31.64 | |
$102.61 | |
3.51M | |
10.33M | |
32.73 | |
$137.49 | |
$81.97 | |
2.40% | |
-- |
Abbott Laboratories (ABT) is trading at $102.61 in after-hours trading as of 2026-09-21 21:04:00, up 0.00% ($0.00) from the regular-session close of $102.61.
After-hours trading shows how investors are pricing ABT after the regular session closes. The current after-hours price is near the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Abbott Laboratories (ABT) moved from $103.36 to $102.98, representing a decline of 0.37% ($0.38).
The stock traded between $100.33 and $105.19 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 10.31 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 37.8%
ABT is currently trading at $102.98, placing it 37.8% of the way from its 52-week low of $81.97 to its 52-week high of $137.49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 115000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Abbott Laboratories (ABT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.